DOCSLIB.ORG

2018 Program Guide & Abstracts

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2018 Program Guide & Abstracts a forum for student scholarship 2018 Program Guide & Abstracts Welcome to QUEST 2018 Welcome students, faculty, and guests to QUEST: A Forum for Student Scholarship. Now in its 29th year, QUEST has become a Youngstown State University (YSU) tradition of excellence in academic achievement, innovation, discovery, and scholarship. QUEST recognizes the outstanding scholarly achievements by YSU students, working in collaboration with YSU’s faculty members. This year’s program includes nearly 400 student participants. The QUEST committee and University administration are grateful for the guidance and commitment of YSU’s dedicated faculty in providing inspiration, motivation, and support for their students and making these presentations possible. Many of these presentations represent scholarly endeavors made possible through individual faculty grants, and through support from the Office of Research University Research Council grants. We extend a special welcome to our keynote speaker, Dr. Donna Nelson. Her expertise in chemistry and her research in student and faculty diversity aligns with QUEST values. We also welcome a collaboration with AGEP (Alliance for Graduate Education and the Professoriate) students who bring diversity to advanced degrees in the STEM fields, and who are both presenting and judging at QUEST. We welcome area College Credit Plus (CCP) students to QUEST, and encourage them to network with AGEP students and YSU students and faculty. We encourage all QUEST participants to actively engage in and appreciate each other’s scholarly activities, seeking to discover new knowledge within those exciting interdisciplinary collaborations. In addition to serving as a forum summarizing prior success, we hope that QUEST serves as a starting point for new partnerships, collaborations, and discovery among students and faculty from all our academic disciplines. Michael A. Hripko Associate Vice President for Research Youngstown State University Keynote Speaker Youngstown State University welcomes Dr. Donna Nelson as the QUEST Keynote Speaker at noon in the Chestnut Room, Kilcawley Center. Dr. Nelson is professor of chemistry at Oklahoma University. She obtained her PhD in chemistry at UT-Austin, and completed her post-doctorate work at Purdue University. Her areas of interest include nanoscience, communicating science to the public, organic chemical education, and scientific workforce development. She serves as an advisor for television programs, such as Breaking Bad, in order to present accurate science to TV audiences. In 2011, she organized the highly-popular “Hollywood Chemistry” symposium at the Anaheim ACS Meeting, and the “Science on the Hollywood Screen” symposium at the Denver ACS Meeting. She has authored over 100 publications and has received numerous honors, including being named an American Chemical Society (ACS) Fellow, a Ford Fellow, and an AAAS Fellow. She was also named a Fulbright Scholar. Her awards include the ACS Israel Award, ACS Nalley Award, Oklahoma Chemist Award, Guggenheim Award, Sigma Xi Faculty Research Award, and the National Science Foundation (NSF) ADVANCE Leadership Award. In addition, Dr. Nelson has been recognized as one of the “21 Leaders for the 21st Century” by Women’s eNews, and a “Woman of Courage” by the National Organization for Women (NOW). Her scientific workforce surveys—of faculty race/ethnicity, gender, and rank in science and engineering at research universities—revealed that women and minorities are much less represented among professors than degree recipients. QUEST 2018 Advisory Committee Coordinators Mr. Michael Hripko Associate VP for Research Office of Research Ms. Sarah Ferguson Graduate Assistant Office of Research Services Faculty and Staff Dr. Amy Cossentino Director Honors College Ms. Emilie Eberth Coordinator of Outreach College of STEM Dr. Diana Fagan Professor Department of Biological Sciences Dr. John Hazy Professor & Graduate Department of Criminal Justice Coordinator and Forensic Sciences Dr. Dr. Matt O’Mansky Associate Professor & Chair Department of Sociology, Anthropology, and Gerontology Dr. Clovis Linkous Professor Department of Chemistry Ms. Sharon Schroeder Assistant Director Metro Credit Honors College Students Ms. Lexi Rager Mathematics Major College of STEM Mr. David Gessler Chemical Engineering & College of STEM Mathematics Major Acknowledgements We appreciate support for QUEST 2018 from the following individuals, organizations, and programs: . YSU Board of Trustees . YSU Faculty Members . Keynote Speaker Dr. Donna Nelson . YSU President, Mr. James P. Tressel . YSU Provost, Dr. Martin A. Abraham . YSU Foundation President, Mr. Paul McFadden . YSU Honors College Students and Director Dr. Amy Cossentino . NOA-AGEP Students and Advisors . Undergraduate Research Council (URC) . College of Liberal Arts and Sciences . Beeghly College of Education . Bitonte College of Health and Human Services . College of Creative Arts and Communications . College of Science, Technology, Engineering, and Mathematics . Williamson College of Business Administration . Kilcawley Center Staff The Unintended Consequences of Innovation Visit the LASS 1510, Critical Questions in LASS Poster Display In from ͺ:30 .m. to ͳͲ:00 .m. Congratulations PenguinThink Contest Winners! From the College of Science, Technology, Engineering & Mathematics May Lynn Einfalt, Contamination of Water Major: Biology Logan Burrows, The Effects of Early Media Exposure on Children Major: Biology, Pre-Med SPECIAL THANKS TO THEIR MENTOR: Ms. Sarah Eisnaugle QUEST 2018: A Forum for Student Scholarship Sessions, Topics, and Rooms 8:30 – 10:00 – Session 1 – Posters (Biology) – Ohio Room ........................................................................ 1 8:30 – 10:00 – Session 2 – Oral Presentations . Respiratory Care – James Gallery ................................................................................................. 8 . Dental Hygiene – Coffelt ............................................................................................................. 11 . Creative & Liberal Arts / Education / Business – Humphrey ...................................................... 15 10:30 – 12:00 – Session 3a – Posters (Engineering Topics) – Ohio Room ............................................... 17 10:30 – 12:00 – Session 3b – Posters (AGEP – STEM Topcis) – Bresnahan 1 & 2 .................................... 22 10:30 – 12:00 – Session 4 – Oral Presentations . Respiratory Care – James Gallery ............................................................................................... 28 . Creative & Liberal Arts / Education – Jones ................................................................................ 31 . Mechanical / Industrial Engineering – Coffelt ............................................................................ 33 . Health & Human Services / Liberal Arts – Humphrey ................................................................. 35 12:00 – 1:15 – Luncheon & Keynote Speaker – Chestnut Room 1:30 – 3:00 – Session 5a – Posters (Various Topics) – Ohio Room .......................................................... 38 1:30 – 3:00 – Session 5b – Posters (STEM Topics) – Bresnahan 1 & 2 ..................................................... 46 1:30 – 3:00 – Session 6 – Oral Presentations . Mechanical Engineering – James Gallery ................................................................................... 51 . STEM Topics – Jones ................................................................................................................... 53 . Physics / Engineering – Coffelt.................................................................................................... 56 . Mechanical/Industrial Engineering – Humphrey ........................................................................ 58 . Biology – Esterly .......................................................................................................................... 60 3:30 – 5:00 – Session 7a – Posters (Chemistry) – Ohio Room ................................................................. 62 3:30 – 5:00 – Session 7b – Posters (Civil Engineering / Environmental Studies) – Bresnahan 1 & 2 ...... 66 3:30 – 5:00 – Session 8 – Oral Presentations . Anthropology / Geography– Jones ............................................................................................. 72 . Health & Human Services / Liberal Arts / Business – Coffelt ...................................................... 74 . Mechanical Engineering – Humphrey ......................................................................................... 76 1 Session 1 8:30 – 10:00 Biology Room: Ohio Poster Identification of Proteins Putatively Secreted by the Yeast Phase of Talaromyces marneffei (Project ID: 221) Victoria Silvis, Cole McKenry Biology - Faculty Sponsors: Dr. Chester Cooper, Dr. Xiangjia Min The virulence of Talaromyces marneffei, a pathogen endemic to Southeast Asia, is associated with the yeast phase of this thermally dimorphic fungus. The yeast phase of T. marneffei thrives in the intracellular milieu of host macrophages. This ability to survive within a normally harsh environment prompted us to hypothesize that the yeast phase of T. marneffei may secrete proteinaceous factors which hinder the normal defensive response of the host macrophage. To assess this hypothesis, 538 putatively secreted T. marneffei proteins were identified using the Fungal Secretome KnowledgeBase. DNA primers were designed to a selected number of
Load more

Recommended publications
  • Diversity and Toxigenicity of Fungi That Cause Pineapple Fruitlet Core Rot
    toxins Article Diversity and Toxigenicity of Fungi that Cause Pineapple Fruitlet Core Rot Bastien Barral 1,2,* , Marc Chillet 1,2, Anna Doizy 3 , Maeva Grassi 1, Laetitia Ragot 1, Mathieu Léchaudel 1,4, Noel Durand 1,5, Lindy Joy Rose 6 , Altus Viljoen 6 and Sabine Schorr-Galindo 1 1 Qualisud, Université de Montpellier, CIRAD, Montpellier SupAgro, Univ d’Avignon, Univ de La Reunion, F-34398 Montpellier, France; [email protected] (M.C.); [email protected] (M.G.); [email protected] (L.R.); [email protected] (M.L.); [email protected] (N.D.); [email protected] (S.S.-G.) 2 CIRAD, UMR Qualisud, F-97410 Saint-Pierre, Reunion, France 3 CIRAD, UMR PVBMT, F-97410 Saint-Pierre, Reunion, France; [email protected] 4 CIRAD, UMR Qualisud, F-97130 Capesterre-Belle-Eau, Guadeloupe, France 5 CIRAD, UMR Qualisud, F-34398 Montpellier, France 6 Department of Plant Pathology, Stellenbosch University, Private Bag X1, Matieland 7600, South Africa; [email protected] (L.J.R.); [email protected] (A.V.) * Correspondence: [email protected]; Tel.: +262-2-62-49-27-88 Received: 14 April 2020; Accepted: 14 May 2020; Published: 21 May 2020 Abstract: The identity of the fungi responsible for fruitlet core rot (FCR) disease in pineapple has been the subject of investigation for some time. This study describes the diversity and toxigenic potential of fungal species causing FCR in La Reunion, an island in the Indian Ocean. One-hundred-and-fifty fungal isolates were obtained from infected and healthy fruitlets on Reunion Island and exclusively correspond to two genera of fungi: Fusarium and Talaromyces.
    [Show full text]
  • Estimated Burden of Fungal Infections in Oman
    Journal of Fungi Article Estimated Burden of Fungal Infections in Oman Abdullah M. S. Al-Hatmi 1,2,3,* , Mohammed A. Al-Shuhoumi 4 and David W. Denning 5 1 Department of microbiology, Natural & Medical Sciences Research Center, University of Nizwa, Nizwa 616, Oman 2 Department of microbiology, Centre of Expertise in Mycology Radboudumc/CWZ, 6500 Nijmegen, The Netherlands 3 Foundation of Atlas of Clinical Fungi, 1214GP Hilversum, The Netherlands 4 Ibri Hospital, Ministry of Health, Ibri 115, Oman; [email protected] 5 Manchester Fungal Infection Group, Manchester Academic Health Science Centre, The University of Manchester, Manchester M13 9PL, UK; [email protected] * Correspondence: [email protected]; Tel.: +968-25446328; Fax: +968-25446612 Abstract: For many years, fungi have emerged as significant and frequent opportunistic pathogens and nosocomial infections in many different populations at risk. Fungal infections include disease that varies from superficial to disseminated infections which are often fatal. No fungal disease is reportable in Oman. Many cases are admitted with underlying pathology, and fungal infection is often not documented. The burden of fungal infections in Oman is still unknown. Using disease frequencies from heterogeneous and robust data sources, we provide an estimation of the incidence and prevalence of Oman’s fungal diseases. An estimated 79,520 people in Oman are affected by a serious fungal infection each year, 1.7% of the population, not including fungal skin infections, chronic fungal rhinosinusitis or otitis externa. These figures are dominated by vaginal candidiasis, followed by allergic respiratory disease (fungal asthma). An estimated 244 patients develop invasive aspergillosis and at least 230 candidemia annually (5.4 and 5.0 per 100,000).
    [Show full text]
  • PRIOR AUTHORIZATION CRITERIA BRAND NAME (Generic) SPORANOX ORAL CAPSULES (Itraconazole)
    PRIOR AUTHORIZATION CRITERIA BRAND NAME (generic) SPORANOX ORAL CAPSULES (itraconazole) Status: CVS Caremark Criteria Type: Initial Prior Authorization Policy FDA-APPROVED INDICATIONS Sporanox (itraconazole) Capsules are indicated for the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: 1. Blastomycosis, pulmonary and extrapulmonary 2. Histoplasmosis, including chronic cavitary pulmonary disease and disseminated, non-meningeal histoplasmosis, and 3. Aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin B therapy. Specimens for fungal cultures and other relevant laboratory studies (wet mount, histopathology, serology) should be obtained before therapy to isolate and identify causative organisms. Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, antiinfective therapy should be adjusted accordingly. Sporanox Capsules are also indicated for the treatment of the following fungal infections in non-immunocompromised patients: 1. Onychomycosis of the toenail, with or without fingernail involvement, due to dermatophytes (tinea unguium), and 2. Onychomycosis of the fingernail due to dermatophytes (tinea unguium). Prior to initiating treatment, appropriate nail specimens for laboratory testing (KOH preparation, fungal culture, or nail biopsy) should be obtained to confirm the diagnosis of onychomycosis. Compendial Uses Coccidioidomycosis2,3
    [Show full text]
  • Taxonomy and Evolution of Aspergillus, Penicillium and Talaromyces in the Omics Era – Past, Present and Future
    Computational and Structural Biotechnology Journal 16 (2018) 197–210 Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/csbj Taxonomy and evolution of Aspergillus, Penicillium and Talaromyces in the omics era – Past, present and future Chi-Ching Tsang a, James Y.M. Tang a, Susanna K.P. Lau a,b,c,d,e,⁎, Patrick C.Y. Woo a,b,c,d,e,⁎ a Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong b Research Centre of Infection and Immunology, The University of Hong Kong, Hong Kong c State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong d Carol Yu Centre for Infection, The University of Hong Kong, Hong Kong e Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, The University of Hong Kong, Hong Kong article info abstract Article history: Aspergillus, Penicillium and Talaromyces are diverse, phenotypically polythetic genera encompassing species im- Received 25 October 2017 portant to the environment, economy, biotechnology and medicine, causing significant social impacts. Taxo- Received in revised form 12 March 2018 nomic studies on these fungi are essential since they could provide invaluable information on their Accepted 23 May 2018 evolutionary relationships and define criteria for species recognition. With the advancement of various biological, Available online 31 May 2018 biochemical and computational technologies, different approaches have been adopted for the taxonomy of Asper- gillus, Penicillium and Talaromyces; for example, from traditional morphotyping, phenotyping to chemotyping Keywords: Aspergillus (e.g. lipotyping, proteotypingand metabolotyping) and then mitogenotyping and/or phylotyping. Since different Penicillium taxonomic approaches focus on different sets of characters of the organisms, various classification and identifica- Talaromyces tion schemes would result.
    [Show full text]
  • AIDS-Related Mycoses in the Paediatric Population
    Current Fungal Infection Reports (2019) 13:221–228 https://doi.org/10.1007/s12281-019-00352-8 PEDIATRIC FUNGAL INFECTIONS (D CORZO-LEON, SECTION EDITOR) AIDS-Related Mycoses in the Paediatric Population B. E. Ekeng1 & O. O. Olusoga2 & R. O. Oladele3 Published online: 16 November 2019 # Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract Purpose of Review Fungal infections account for significant morbidity and mortality in HIV-infected children particularly in developing countries where there is lack of skilled personnel and infrastructure to make the appropriate diagnosis. This is further compounded by poor availability and accessibility of the antifungals needed to treat these infections. The purpose of this review is to highlight the paucity of data on AIDS-related mycoses in the paediatric age group and make appropriate recommendations to address challenges associated with mycoses in this population. Recent Findings These infections are categorised in two broad groups in this population: mucocutaneous, which commonly affects nutrition and adherence to therapy and invasive fungal infections which are life-threatening. A literature search revealed a total of 29 published literatures across all AIDS-related mycoses in the paediatric population. Summary Research to determine the true burden of the problem and greater funding with implementation of a package of care that will result in substantial reductions in morbidity and mortality in relation to AIDS-related mycoses in children are needed. It is imperative that the programmatic optimal package of care for children with advanced HIV disease is designed and implemented. Keywords Mycoses . Paediatric . Advanced HIV disease . HIV/AIDS . LMICs Introduction defined as CD4+ of < 200 cells/mm3 or stage 3/4 disease (WHO staging) in children over 5 years of age, while any Advanced HIV disease (AHD) is one of the most current HIV-infected child less than 5 years is regarded as AHD [2••].
    [Show full text]
  • Phylogeny and Nomenclature of the Genus Talaromyces and Taxa Accommodated in Penicillium Subgenus Biverticillium
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector available online at www.studiesinmycology.org StudieS in Mycology 70: 159–183. 2011. doi:10.3114/sim.2011.70.04 Phylogeny and nomenclature of the genus Talaromyces and taxa accommodated in Penicillium subgenus Biverticillium R.A. Samson1, N. Yilmaz1,6, J. Houbraken1,6, H. Spierenburg1, K.A. Seifert2, S.W. Peterson3, J. Varga4 and J.C. Frisvad5 1CBS-KNAW Fungal Biodiversity Centre, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands; 2Biodiversity (Mycology), Eastern Cereal and Oilseed Research Centre, Agriculture & Agri-Food Canada, 960 Carling Ave., Ottawa, Ontario, K1A 0C6, Canada, 3Bacterial Foodborne Pathogens and Mycology Research Unit, National Center for Agricultural Utilization Research, 1815 N. University Street, Peoria, IL 61604, U.S.A., 4Department of Microbiology, Faculty of Science and Informatics, University of Szeged, H-6726 Szeged, Közép fasor 52, Hungary, 5Department of Systems Biology, Building 221, Technical University of Denmark, DK-2800, Kgs. Lyngby, Denmark; 6Microbiology, Department of Biology, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands. *Correspondence: R.A. Samson, [email protected] Abstract: The taxonomic history of anamorphic species attributed to Penicillium subgenus Biverticillium is reviewed, along with evidence supporting their relationship with teleomorphic species classified inTalaromyces. To supplement previous conclusions based on ITS, SSU and/or LSU sequencing that Talaromyces and subgenus Biverticillium comprise a monophyletic group that is distinct from Penicillium at the generic level, the phylogenetic relationships of these two groups with other genera of Trichocomaceae was further studied by sequencing a part of the RPB1 (RNA polymerase II largest subunit) gene.
    [Show full text]
  • Genome Sequencing and Analysis of Talaromyces Pinophilus Provide
    www.nature.com/scientificreports OPEN Genome sequencing and analysis of Talaromyces pinophilus provide insights into biotechnological Received: 4 October 2016 Accepted: 3 March 2017 applications Published: xx xx xxxx Cheng-Xi Li, Shuai Zhao, Ting Zhang, Liang Xian, Lu-Sheng Liao, Jun-Liang Liu & Jia-Xun Feng Species from the genus Talaromyces produce useful biomass-degrading enzymes and secondary metabolites. However, these enzymes and secondary metabolites are still poorly understood and have not been explored in depth because of a lack of comprehensive genetic information. Here, we report a 36.51-megabase genome assembly of Talaromyces pinophilus strain 1–95, with coverage of nine scaffolds of eight chromosomes with telomeric repeats at their ends and circular mitochondrial DNA. In total, 13,472 protein-coding genes were predicted. Of these, 803 were annotated to encode enzymes that act on carbohydrates, including 39 cellulose-degrading and 24 starch-degrading enzymes. In addition, 68 secondary metabolism gene clusters were identified, mainly including T1 polyketide synthase genes and nonribosomal peptide synthase genes. Comparative genomic analyses revealed that T. pinophilus 1–95 harbors more biomass-degrading enzymes and secondary metabolites than other related filamentous fungi. The prediction of theT. pinophilus 1–95 secretome indicated that approximately 50% of the biomass-degrading enzymes are secreted into the extracellular environment. These results expanded our genetic knowledge of the biomass-degrading enzyme system of T. pinophilus and its biosynthesis of secondary metabolites, facilitating the cultivation of T. pinophilus for high production of useful products. Talaromyces pinophilus, formerly designated Penicillium pinophilum, is a fungus that produces biomass-degrading enzymes such as α-amylase1, cellulase2, endoglucanase3, xylanase2, laccase4 and α-galactosidase2.
    [Show full text]
  • A Geosentinel Analysis, 1997–2017
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author J Travel Manuscript Author Med. Author manuscript; Manuscript Author available in PMC 2019 July 15. Published in final edited form as: J Travel Med. 2018 August 01; 25(1): . doi:10.1093/jtm/tay055. Epidemiological aspects of travel-related systemic endemic mycoses: a GeoSentinel analysis, 1997–2017 Helmut J. F. Salzer1, Rhett J. Stoney2, Kristina M. Angelo2, Thierry Rolling3,4, Martin P. Grobusch5, Michael Libman6, Rogelio López-Vélez7, Alexandre Duvignaud8, Hilmir Ásgeirsson9,10, Clara Crespillo-Andújar11, Eli Schwartz12, Philippe Gautret13, Emmanuel Bottieau14, Sabine Jordan3, Christoph Lange1,15,16, Davidson H. Hamer17,18,*, and GeoSentinel Surveillance Network 1Division of Clinical Infectious Diseases and German Center for Infection Research Tuberculosis Unit, Research Center Borstel, Leibniz Lung Center, Borstel, Germany 2Travelers’ Health Branch, Division of Global Migration and Quarantine, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA 3Section of Infectious Diseases and Tropical Medicine, 1st Department of Internal Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany 4Department of Clinical Research, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany 5Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, The Netherlands 6J. D. MacLean Centre for Tropical Diseases, McGill University, Montreal,
    [Show full text]
  • New Xerophilic Species of Penicillium from Soil
    Journal of Fungi Article New Xerophilic Species of Penicillium from Soil Ernesto Rodríguez-Andrade, Alberto M. Stchigel * and José F. Cano-Lira Mycology Unit, Medical School and IISPV, Universitat Rovira i Virgili (URV), Sant Llorenç 21, Reus, 43201 Tarragona, Spain; [email protected] (E.R.-A.); [email protected] (J.F.C.-L.) * Correspondence: [email protected]; Tel.: +34-977-75-9341 Abstract: Soil is one of the main reservoirs of fungi. The aim of this study was to study the richness of ascomycetes in a set of soil samples from Mexico and Spain. Fungi were isolated after 2% w/v phenol treatment of samples. In that way, several strains of the genus Penicillium were recovered. A phylogenetic analysis based on internal transcribed spacer (ITS), beta-tubulin (BenA), calmodulin (CaM), and RNA polymerase II subunit 2 gene (rpb2) sequences showed that four of these strains had not been described before. Penicillium melanosporum produces monoverticillate conidiophores and brownish conidia covered by an ornate brown sheath. Penicillium michoacanense and Penicillium siccitolerans produce sclerotia, and their asexual morph is similar to species in the section Aspergilloides (despite all of them pertaining to section Lanata-Divaricata). P. michoacanense differs from P. siccitol- erans in having thick-walled peridial cells (thin-walled in P. siccitolerans). Penicillium sexuale differs from Penicillium cryptum in the section Crypta because it does not produce an asexual morph. Its ascostromata have a peridium composed of thick-walled polygonal cells, and its ascospores are broadly lenticular with two equatorial ridges widely separated by a furrow. All four new species are xerophilic.
    [Show full text]
  • Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: an ECMM Consensus Statement
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 30 August 2020 doi:10.20944/preprints202008.0672.v1 Review Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement Jeffrey D. Jenks 1,2,3,*, Jean-Pierre Gangneux4,12*, Ilan S. Schwartz5,12*, Ana Alastruey- Izquierdo6,12*, Katrien Lagrou7,8,12*, George R. Thompson III 9,*, Cornelia Lass-Flörl10,12* and Martin Hoenigl 2,3,11,12*,†, on behalf of the European Confederation of Medical Mycology (ECMM)13 1 Division of General Internal Medicine, Department of Medicine, University of California San Diego, San Diego, CA 92103, United States of America; [email protected] 2 Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, CA 92103, United States of America; [email protected] 3 Clinical and Translational Fungal-Working Group, University of California San Diego, La Jolla, CA 92093, USA 4 Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) – UMR_S 1085, F-35000 Rennes, France; [email protected] 5 Division of Infectious Diseases, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada; [email protected] 6 Mycology Reference Laboratory, National Centre for Microbiology. Instituto de Salud Carlos III. Majadahonda, Madrid, Spain; [email protected] 7 Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium;
    [Show full text]
  • Open Letter to Who & Act-A: We Need Affordable
    OPEN LETTER TO WHO & ACT-A: WE NEED AFFORDABLE TREATMENTS FOR THE RISE OF SERIOUS INVASIVE FUNGAL DISEASES THAT ARE LIFE THREATENING FOR COVID-19 SURVIVORS AND HIV+ PEOPLE 23 June 2021 Dear Dr Tedros Adhanom Ghebreyesus, Dr Mariângela Simão, and co-Chairs of the ACT-A Therapeutics Pillar, Dr Phillipe Duneton and Sir Jeremy Farrar, We are writing regarding the urgent need for liposomal amphotericin B (L-AmB) and other drugs for the treatment of severe fungal infections, including the epidemic of mucormycosis (“black fungus”), a Covid-related complication that has claimed the lives to date of more than 10,000 people and resulted in severe disfigurement of many more in India with cases now reported in Nepal. L-AmB is also a crucial treatment for cryptococcal meningitisi, and the long-standing neglected disease, visceral leishmaniasis (kala azar),ii as well as other systemic fungal infectionsiii. Mucormycosis is an otherwise rare, deadly fungal infection that is increasingly affecting Covid-19 patients and survivors in India. According to the government of India, the number of mucormycosis cases increased from 9,000 in late May to 28,252 cases on 7 June 2021. Nepal is also seeing growing numbers of mucormycosis among people with Covid-19.iv We are deeply concerned about the lack of sufficient, predictable, and affordable supply of L- AmB. A high volume of L-AmB vials are needed to treat mucormycosis: 150-300 vials per person.v In India, and perhaps now in Nepal, people are going without treatment or with suboptimal doses. Globally, an estimated 6 million vials of L-AmB are needed to treat today’s cases of cryptococcal meningitis, leishmaniasis (kala azar), and mucormycosis.vi Access to posaconazole (preferably delayed release tablets and injections) is also critical.vii While there are several manufacturers of posaconazole injection and tablets, prices remain high in the private market and governments in affected countries have yet to develop guidelines for mucormycosis and have not made the drug available.
    [Show full text]
  • Black Fungus: a New Threat Uddin KN
    Editorial (BIRDEM Med J 2021; 11(3): 164-165) Black fungus: a new threat Uddin KN Fungal infections, also known as mycoses, are Candida spp. including non-albicans Candida (causing traditionally divided into superficial, subcutaneous and candidiasis), p. Aspergillus spp. (causing aspergillosis), systemic mycoses. Cryptococcus (causing cryptococcosis), Mucormycosis previously called zygomycosis caused by Zygomycetes. What are systemic mycoses? These fungi are found in or on normal skin, decaying Systemic mycoses are fungal infections affecting vegetable matter and bird droppings respectively but internal organs. In the right circumstances, the fungi not exclusively. They are present throughout the world. enter the body via the lungs, through the gut, paranasal sinuses or skin. The fungi can then spread via the Who are at risk of systemic mycoses? bloodstream to multiple organs, often causing multiple Immunocompromised people are at risk of systemic organs to fail and eventually, result in the death of the mycoses. Immunodeficiency can result from: human patient. immunodeficiency virus (HIV) infection, systemic malignancy (cancer), neutropenia, organ transplant What causes systemic mycoses? recipients including haematological stem cell transplant, Patients who are immunocompromised are predisposed after a major surgical operation, poorly controlled to systemic mycoses but systemic mycosis can develop diabetes mellitus, adult-onset immunodeficiency in otherwise healthy patients. Systemic mycoses can syndrome, very old or very young. be split between two main varieties, endemic respiratory infections and opportunistic infections. What are the clinical features of systemic mycoses? The clinical features of a systemic mycosis depend on Endemic respiratory infections the specific infection and which organs have been Fungi that can cause systemic infection in people with affected.
    [Show full text]